Xoft microTube Inc.
This article was originally published in Start Up
Executive Summary
Xoft microTube Inc.'s micro-miniature flexible x-ray tubes are designed to conform to any body cavity and deliver very high doses of radiation. For the company's lead indication, breast cancer, Xoft's goal is to provide single fraction radiation therapy delivered to the surgical margins after tumor resection in just one 30-minute treatment.
You may also be interested in...
First Off The Blocks, Fresenius Launches US Tocilizumab Biosimilar
Fresenius Kabi has kicked off competition to Genentech’s Actemra in the US, launching its Tyenne biosimilar version of tocilizumab.
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.